Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Cisatracurium recalled?

Yes — there is an active recall. 3 ongoing FDA recalls mention Cisatracurium (6 total). Check the affected lots below.

Most common reason: Wrong potency / content (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Cisatracurium. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Cisatracurium recalls on record

none so far in 2026; 6 on record, newest first
Class I · High risk

Cisatracurium Besylate Injection

Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium

Terminated Labeling / mix-up Meitheal Pharmaceuticals Inc NDC 71288-712-05 D-0286-2021
Class II · Moderate risk

Cisatracurium Besylate Injection

Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label. The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.

Terminated Chemical / undeclared Fresenius Kabi USA, LLC NDC 63323-417-10 D-0819-2016
Class II · Moderate risk

Cisatracurium Besylate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-589-2015